Blog
August 07, 2020

Watch The Recording of Our Webinar: How COVID-19 Affects the PKD Population- Presented in French

The PKD Foundation of Canada presents: How COVID-19 Affects the PKD Population- Presented in French

Watch the Recording Now!

Watch the live recording HERE!

COVID-19 is a serious health concern and the impact on our lives continues to evolve on a daily basis. In these unprecedented times, individuals with pre-existing conditions need to be especially careful. It is our goal to provide you with up-to-date information as it relates to this virus, and to help ease your mind during this challenging time.

The PKD Foundation of Canada was proud to present this complimentary webinar on July 9th, How COVID-19 Affects the PKD Community. This webinar gave participants the opportunity to ask questions to one of Canada’s leading ADPKD specialists.

We invite patients and their loved ones to watch the recording of this webinar to learn about the following topics and more:

  • Am I more likely to get COVID-19 due to ADPKD?
  • Am I more at risk of developing severe complications?
  • How to avoid catching COVID-19?
  • What should I do if I get COVID-19 and have ADPKD?
  • How will treatment of ADPKD change during the COVID-19 pandemic?
  • Are there some medications to avoid or stop taking?

    This webinar was live: Thursday July 9th 2020- 7:00- 9:00pm EST
    You can watch it now: From the comfort of your home!
    Speaker: Dr Guillaume Bollée

Watch the live recording HERE!

About the Speaker: 

Dr Guillaume Bollée is a nephrologist with expertise in the field of hereditary and rare kidney diseases. He is Director of the Kidney Rare Disease Clinic at the Montreal Clinical Research Institute (IRCM).Assessing and treating patients with  polycystic kidney disease  is one of the main focuses of this clinic. Dr. Bollée also practices medicine at the Centre hospitalier de l’Université de Montréal (CHUM) and is an Assistant Clinical Professor in the Department of Medicine at the Faculty of Medicine of the Université de Montréal. He is the author and co-authored of numerous articles including rare and genetic renal diseases issues. Dr Bollée has already participated to several PKDFOC forums.